Sign In
27 Mar 2018 15:43
27 March 2018
Accrol Group Holdings plc
(the "Company")
Statement re Share Price Movement
Accrol Group Holdings plc (AIM: ACRL), the AIM-listed independent tissue converter, notes its share price movement today. The Company knows of no reason for the recent share price movement and has no further update to the trading update released on 19 March 2018.
For further information, please contact: | |
Accrol Group Holdings plc | |
Gareth Jenkins, Chief Executive Officer | +44 (0) 1254 278 844 |
Martin Leitch, Interim Chief Finance Officer | +44 (0) 1254 278 844 |
Zeus Capital Limited (Nominated Adviser & Broker) | |
Dan Bate / Andrew Jones | +44 (0) 161 831 1512 |
Dominic King / John Goold | +44 (0) 203 829 5000 |
Belvedere Communications Limited | |
Cat Valentine (cvalentine@belvederepr.com) | +44 (0) 7715 769 078 |
ACRL.L (ACRL)
Follow the stocks
